P2P: Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults

Sponsor
UConn Health (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05374395
Collaborator
Oregon Social Learning Center (Other), University of Texas at Austin (Other)
1,750
2
41.5

Study Details

Study Description

Brief Summary

Emerging adults (ages 18-25) are at higher risk for substance use disorders, including opiate addiction, than any other age group but are also more likely to drop out early from substance use treatment services. This project will evaluate an enhancement to usual services, delivered by peer recovery supports, specifically aimed at improving treatment adherence and reducing dropout in this age group. The study will also answer key questions about risk factors for dropout among emerging adults and the financial sustainability of enhancing services to reduce dropout.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Peer Recovery Support-Delivered Dropout Prevention enhancement
N/A

Detailed Description

Emerging adults (EAs; ages 18-25) have higher rates of substance use disorders than any other age group and have been hit particularly hard by the opioid crisis. EAs also demonstrate poor adherence to healthcare regimens associated with substance use services, with higher dropout rates and lower service utilization than any other age group. This poor adherence leads to devastating outcomes, including continued substance use, incarceration, and overdose. In addition, high dropout rates contribute to skyrocketing costs to treatment systems as a result of more acute service needs, expensive service utilization, and long waitlists. Cost-effective strategies that are aimed at improving treatment adherence to substance use services and tailored to meet the unique developmental needs of EAs are an imminent need. Further, little is known about risk factors for dropout specific to this age group, hindering effective system responses to this significant problem.

At the same time, substance use service systems are increasingly using peer recovery supports (PRS; i.e., paraprofessionals who have "lived experience" with substance use problems) to bolster treatment outcomes without incurring considerable additional costs. However, services delivered by PRS have not been tailored specifically to reduce EA dropout, and few have been rigorously tested at all. The current study will evaluate an innovative EA-specific dropout prevention enhancement to usual treatment services, delivered by PRS in community-based substance use treatment clinics (Aim 1). The investigators will employ a stepped-wedge cluster randomized design, resulting in each clinic having a longitudinal usual services phase and a longitudinal dropout prevention phase. The two phases will be compared on rates of EA dropout and service utilization using objective data from clinical charts.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1750 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
A stepped-wedge cluster randomized design will include five blocks of two clinics randomized to the timing of the Peer recovery support-delivered Dropout Prevention enhancement, with each clinic having two phases: a longitudinal Usual Services (US) Phase and a longitudinal Usual Services + Peer recovery support-delivered Dropout Prevention (PDP) enhancement Phase. All clusters will have a baseline phase and will be randomized to the timing of the PDP phase. Once randomized to begin, all clusters will have a 24-month US+PDP Phase.A stepped-wedge cluster randomized design will include five blocks of two clinics randomized to the timing of the Peer recovery support-delivered Dropout Prevention enhancement, with each clinic having two phases: a longitudinal Usual Services (US) Phase and a longitudinal Usual Services + Peer recovery support-delivered Dropout Prevention (PDP) enhancement Phase. All clusters will have a baseline phase and will be randomized to the timing of the PDP phase. Once randomized to begin, all clusters will have a 24-month US+PDP Phase.
Masking:
Single (Outcomes Assessor)
Masking Description:
Primary outcomes will come from the clinics' chart data. Individuals pulling data from charts will be blind to study condition.
Primary Purpose:
Health Services Research
Official Title:
Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults
Anticipated Study Start Date :
Sep 15, 2022
Anticipated Primary Completion Date :
Mar 1, 2026
Anticipated Study Completion Date :
Mar 1, 2026

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Services

clinics will continue to deliver their normal outpatient services

Experimental: Peer Recovery Support - Delivered Dropout Prevention + Usual Services

clinics will continue to deliver their normal outpatient services plus the peer recovery support-delivered dropout prevention enhancement

Behavioral: Peer Recovery Support-Delivered Dropout Prevention enhancement
Peer recovery supports will meet with emerging adults for four weekly sessions plus monthly check-ins during the next two months. Peer recovery supports will engage the emerging adults in motivational and skills-based strategies aimed at increasing adherence to services and attendance to treatment sessions.

Outcome Measures

Primary Outcome Measures

  1. Number of patients who dropout from substance use services [90 days from initiation of treatment]

    Data will come from de-identified clinical charts. Dropout will be defined in two ways: 1) patient did not complete the total number of sessions prescribed in the treatment plan and 2) patient was in treatment for less than 90 days.

  2. Number of missed sessions and no show sessions [90 days from initiation of treatment]

    Data will come from de-identified clinical charts. Number of missed sessions or no shows will be evaluated based on the number of scheduled sessions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18-25

  • initiating outpatient treatment for a substance use problem

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • UConn Health
  • Oregon Social Learning Center
  • University of Texas at Austin

Investigators

  • Principal Investigator: Kristyn Zajac, PhD, UConn Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kristyn Zajac, Associate Professor, UConn Health
ClinicalTrials.gov Identifier:
NCT05374395
Other Study ID Numbers:
  • 21-097-2
First Posted:
May 16, 2022
Last Update Posted:
Jul 8, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kristyn Zajac, Associate Professor, UConn Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2022